Dicicco Wendy F Insider Trades

Insider Trading History

Track insider trading activity for Dicicco Wendy F. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
EyePoint Pharmaceuticals
EyePoint Pharmaceuticals EYPT
Director
Holding Value $490k 40,000 shares
Last Trade
Jan 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$699k 40,000 shares
$17.48
$12.26
EyePoint Pharmaceuticals
EyePoint Pharmaceuticals EYPT
Director
Holding Value $490k 40,000 shares
Last Trade
Jan 03, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$330k 40,000 shares
$8.26
$12.26
EyePoint Pharmaceuticals
EyePoint Pharmaceuticals EYPT
Director
Holding Value $122k 9,967 shares
Last Trade
Aug 20, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$20k 2,567 shares
$7.79
$12.26
Akari Therapeutics Plc
Akari Therapeutics Plc AKTX
Interim CFO
Holding Value $0 0 shares
Last Trade
Jul 17, 2024 Sale
$19.2M 5,000,000 shares
$3.83
$15.84
Akari Therapeutics Plc
Akari Therapeutics Plc AKTX
Interim CFO
Holding Value $2.51B 158,473,915 shares
Last Trade
May 01, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$280M 158,473,915 shares
$1.77
$15.84
EyePoint Pharmaceuticals
EyePoint Pharmaceuticals EYPT
Director
Holding Value $307k 25,014 shares
Last Trade
Jan 05, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$510k 25,014 shares
$20.40
$12.26
EyePoint Pharmaceuticals
EyePoint Pharmaceuticals EYPT
Director
Holding Value $320k 26,100 shares
Last Trade
Jun 20, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$180k 26,100 shares
$6.90
$12.26
EyePoint Pharmaceuticals
EyePoint Pharmaceuticals EYPT
Director
Holding Value $159k 13,000 shares
Last Trade
Jun 20, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$89.7k 13,000 shares
$6.90
$12.26
EyePoint Pharmaceuticals
EyePoint Pharmaceuticals EYPT
Director
Holding Value $0 0 shares
Last Trade
Feb 09, 2023 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$12.5k 3,000 shares
$4.17
$12.26
EyePoint Pharmaceuticals
EyePoint Pharmaceuticals EYPT
Director
Holding Value $90.7k 7,400 shares
Last Trade
Feb 09, 2023 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$12.5k 3,000 shares
$4.17
$12.26
Swk Holdings
Swk Holdings SWKH
Director
Holding Value $98.3k 6,182 shares
Last Trade
Dec 30, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$10.9k 779 shares
$13.98
$15.90
Swk Holdings
Swk Holdings SWKH
Director
Holding Value $85.9k 5,403 shares
Last Trade
Dec 30, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$15.7k 1,120 shares
$13.98
$15.90
Swk Holdings - 9% NT REDEEM 31/01/2027 USD 25
Swk Holdings - 9% NT REDEEM 31/01/2027 USD 25 SWKHL
Director
Holding Value $159k 6,182 shares
Last Trade
Dec 30, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$25.65
Renovacor
Renovacor RCOR
Chief Financial Officer
Holding Value $0 0 shares
Last Trade
Dec 01, 2022 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$497k 155,325 shares
$3.20
$3.20
Renovacor
Renovacor RCOR
Chief Financial Officer
Holding Value $13.9k 4,329 shares
Last Trade
Dec 01, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$13.9k 4,329 shares
$3.20
$3.20
Swk Holdings - 9% NT REDEEM 31/01/2027 USD 25
Swk Holdings - 9% NT REDEEM 31/01/2027 USD 25 SWKHL
Director
Holding Value $89.1k 3,474 shares
Last Trade
Sep 30, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$25.65
Swk Holdings - 9% NT REDEEM 31/01/2027 USD 25
Swk Holdings - 9% NT REDEEM 31/01/2027 USD 25 SWKHL
Director
Holding Value $110k 4,283 shares
Last Trade
Sep 30, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$25.65
Swk Holdings
Swk Holdings SWKH
Director
Holding Value $55.2k 3,474 shares
Last Trade
Sep 30, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$15.7k 1,162 shares
$13.47
$15.90
Swk Holdings
Swk Holdings SWKH
Director
Holding Value $68.1k 4,283 shares
Last Trade
Sep 30, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$10.9k 809 shares
$13.47
$15.90
Swk Holdings - 9% NT REDEEM 31/01/2027 USD 25
Swk Holdings - 9% NT REDEEM 31/01/2027 USD 25 SWKHL
Director
Holding Value $59.3k 2,312 shares
Last Trade
Jun 30, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$25.65

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up